Efficacy of Barley water (Hordeum vulgare) in clinical outcome of COVID-19 patients

Efficacy of Barley water (Hordeum vulgare) in clinical outcome of COVID-19 patients hospitalized in Shiraz: a single blind, randomized controlled clinical study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150830023823N3

Enrollment

Registered

2020-12-06

Start date

2020-11-15

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. COVID-19, virus identified

Interventions

Intervention 1: Intervention group: current medications for this disease according to the approved protocol, in addition to 250 cc of barley water daily (around 11 am). Intervention 2: Control group:

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with a definitive diagnosis of pneumonia (pneumonitis) caused by COVID 19 according to the national guidelines for the new corona virus that hospitalized in selected hospitals for corona virus in Shiraz. Patients are not in the severe group and do not need care in the intensive care unit (ICU care) age>18 Patients don't receive antiviral medication prior to enrollment. The disease is confirmed by PCR or CT scan.

Exclusion criteria

Exclusion criteria: Pregnancy Chronic kidney disease History of allergy to barley

Design outcomes

Primary

Measure	Time frame
Fever. Timepoint: Before and after the intervention In the form of daily. Method of measurement: Thermometer.;Cough. Timepoint: daily. Method of measurement: Patient history.;Respiratory rate. Timepoint: daily. Method of measurement: visual by nurse.;Chills. Timepoint: daily. Method of measurement: Patient history.;Body pain. Timepoint: daily. Method of measurement: Patient history with Visual Analog Scale.;Duration of hospitalization. Timepoint: daily. Method of measurement: patient chart.	—

Measure

Time frame

Fever. Timepoint: Before and after the intervention In the form of daily. Method of measurement: Thermometer.;Cough. Timepoint: daily. Method of measurement: Patient history.;Respiratory rate. Timepoint: daily. Method of measurement: visual by nurse.;Chills. Timepoint: daily. Method of measurement: Patient history.;Body pain. Timepoint: daily. Method of measurement: Patient history with Visual Analog Scale.;Duration of hospitalization. Timepoint: daily. Method of measurement: patient chart.

—

Secondary

Measure	Time frame
Duration of recovery of each of the clinical symptoms(fever, dry cough, respiratory rate). Timepoint: daily. Method of measurement: clinical symptoms registration form according to the national guidelines of the new corona virus.;Side effect such as nausea, bloating and constipation. Timepoint: daily. Method of measurement: drug side effect registration form.;CRP. Timepoint: Start and end of the intervention. Method of measurement: Biochemical Auto analyzer Instrument.	—

Measure

Time frame

Duration of recovery of each of the clinical symptoms(fever, dry cough, respiratory rate). Timepoint: daily. Method of measurement: clinical symptoms registration form according to the national guidelines of the new corona virus.;Side effect such as nausea, bloating and constipation. Timepoint: daily. Method of measurement: drug side effect registration form.;CRP. Timepoint: Start and end of the intervention. Method of measurement: Biochemical Auto analyzer Instrument.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Tavakoli

Shiraz University of Medical Sciences

tavakkolia@sums.ac.ir+98 71 3234 5145

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026